Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.81 | 14.84 |
| PEG Ratio (TTM) | 0.17 | -0.11 |
| P/S Ratio (TTM) | N/A | 2.61 |
| P/B Ratio (TTM) | 1.35 | 1.36 |
| P/FCF Ratio (TTM) | N/A | 5.84 |
| Price to 5YR AVG Earnings Ratio | 21.10 | 15.03 |
| Price to 5YR AVG FCF Ratio | 23.71 | 9.32 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.55% | 0.94% |
| ROE (TTM) | 8.17% | 9.38% |
| Net Profit Margin (TTM) | 21.37% | 16.47% |
| ROIC 5YR AVG | 11.56% | 17.23% |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.07% | 2.96% | 9.07% |
| Revenue | -1.78% | 16.26% | 14.60% |
| Net Income | -2.94% | 18.35% | 23.57% |
| Cash Flow | 57.11% | 1,336.68% | 817.66% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 12.29 |
| Quick Ratio (TTM) | N/A | 12.50 |
| D/E Ratio (TTM) | 0.38 | 1.03 |
| Interest Coverage (TTM) | 2.36 | 0.73 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 1.75 | 0.43 |
| LTL to 5YR AVG FCF | 6.64 | 5.76 |
| Shares Outstanding Growth 5YR AVG | 12.21% | 60.52% |